1982
DOI: 10.1002/ajh.2830130106
|View full text |Cite
|
Sign up to set email alerts
|

Clinical, hematological, and biochemical features of Hb SC disease

Abstract: Twenty-seven patients were seen and followed at our Sickle Cell Center over a period of seven years. Their clinical, hematological, and biochemical features were determined and compared to those of patients with sickle cell anemia who were concurrently investigated. The data indicate that the mild anemia of hemoglobin (Hb) SC disease is slightly microcytic and hyperchromatic. Parameters of hemolysis and the complications of chronic hemolytic anemia (cholelithiasis, leg ulcers, hepatomegaly, and cardiomegaly) a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
58
1
3

Year Published

1984
1984
2012
2012

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 92 publications
(65 citation statements)
references
References 35 publications
3
58
1
3
Order By: Relevance
“…sVCAM-1 thus most likely reflects vascular endothelial activation in sickle cell disease. A fundamental difference between the HbSS and HbSC genotypes is the lower concentration of sickle hemoglobin in red cells of HbSC patients with subsequently less in vivo sickling-desickling and red cell membrane changes, less exposure of the endothelium to reactive oxygen species, less circulating rigid irreversibly sickled erythrocytes, and a lower rate of hemolysis [12,[31][32][33]. Such factors can all activate and damage endothelial cells, and the fact that these occur to a greater extent in HbSS patients as compared to HbSC patients may explain the more profound serum sVCAM-1 enhancements in HbSS subjects as compared to HbSC patients (without increased vWF levels in this last group) [34][35][36][37].…”
Section: Discussionmentioning
confidence: 99%
“…sVCAM-1 thus most likely reflects vascular endothelial activation in sickle cell disease. A fundamental difference between the HbSS and HbSC genotypes is the lower concentration of sickle hemoglobin in red cells of HbSC patients with subsequently less in vivo sickling-desickling and red cell membrane changes, less exposure of the endothelium to reactive oxygen species, less circulating rigid irreversibly sickled erythrocytes, and a lower rate of hemolysis [12,[31][32][33]. Such factors can all activate and damage endothelial cells, and the fact that these occur to a greater extent in HbSS patients as compared to HbSC patients may explain the more profound serum sVCAM-1 enhancements in HbSS subjects as compared to HbSC patients (without increased vWF levels in this last group) [34][35][36][37].…”
Section: Discussionmentioning
confidence: 99%
“…Among the 69% of foreign born patients, the mean duration of residence in France was 13.8 years and the mean duration of follow up at the center was 5.1 years. Fifty-eight percent of female patients had been pregnant with a mean of 1.9 children per woman and 32 spontaneous abortions were reported in 12 females (5 multiple abortions, range [2][3][4][5][6][7][8][9][10][11]. High body mass index (≥25kg/m 2 ) and blood hypertension (> 130/80 mmHg) were reported in 33% and 14% of HbSC patients, respectively.…”
Section: Demographic Findingsmentioning
confidence: 99%
“…The main reason is that HbC enhances the formation of intracellular polymer of HbS by dehydrating red cells. 2,3 The major acute features of SCA are recurrent painful vasoocclusive crisis (VOC) and acute chest syndrome (ACS), priapism and anemia. Chronic organ dysfunctions are of increasing concern in adult patients leading to lifethreatening end-stage organ failures.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Ten percentage of SCA patients admitted to hospitals have hepatic complications [13,14] and 50% of SCA patients in crisis have abnormal liver function tests [15].…”
Section: Liver Disease In Sca Patientsmentioning
confidence: 99%